Page last updated: 2024-10-30

mesalamine and Ureteral Obstruction

mesalamine has been researched along with Ureteral Obstruction in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben-Ami, H1
Lavy, A1
Behar, DM1
Ginesin, Y1
Fischer, D1
Edoute, Y1

Other Studies

1 other study available for mesalamine and Ureteral Obstruction

ArticleYear
Left hydronephrosis caused by Crohn disease successfully treated conservatively.
    The American journal of the medical sciences, 2000, Volume: 320, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Humans; Hyd

2000